Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
gptkb:FDA
1996 |
| gptkbp:ATCCode |
S01EE01
|
| gptkbp:contraindication |
hypersensitivity to latanoprost
|
| gptkbp:drugClass |
prostaglandin analogue
|
| gptkbp:form |
eye drops
|
| gptkbp:genericName |
gptkb:latanoprost
|
| gptkbp:halfLife |
17 minutes (in aqueous humor)
|
| https://www.w3.org/2000/01/rdf-schema#label |
Xalatan
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:mechanismOfAction |
increases outflow of aqueous humor
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
ophthalmic
|
| gptkbp:sideEffect |
eye irritation
eyelash changes increased brown pigmentation of iris |
| gptkbp:storage |
refrigerate before opening
store at room temperature after opening |
| gptkbp:usedFor |
glaucoma
ocular hypertension |
| gptkbp:bfsParent |
gptkb:Pharmacia_&_Upjohn
|
| gptkbp:bfsLayer |
6
|